Fig. 3From: Genome engineering of induced pluripotent stem cells to manufacture natural killer cell therapiesSources of NK cells. Current NK therapies use NK cells from the following sources: primary PB-NK cells, primary CB-NK cells, NK cell lines, and recently, iPSC-NK cells, each with its own benefits and limitations. See Supplemental Tables 1 and 2 (Additional files 1 and 2) for a list of products in clinical trialsBack to article page